TherapyMatch-D
Overview
This study is no longer looking for new participants but is still ongoing.
We want to explore if matching certain subgroups of people with depression to a particular therapy would help patients. In this pilot randomized controlled trial, we will randomly assign some Talking Therapies sites to an experimental group, and others to a control group. The TherapyMatch-D computer programme will give a personalised treatment recommendation to some patients in the experimental group.
Summary
What is the study about?
Two therapies for depression routinely offered in Talking Therapy sites are cognitive behavioural therapy (CBT), and person-centred experiential therapy (PCE; also known as counselling for depression).
Both therapies are equally effective. However, a past published study
with archival data suggested there are certain characteristics (such as age, baseline severity, and use of medication) which might make some people more likely to recover from depression if they are matched to either CBT or PCE.
What are you trying to find out?
This study is no longer looking for new participants but is still ongoing.
We want to explore if matching certain subgroups of people with depression to a particular therapy would help patients. In this pilot randomized controlled trial, we will randomly assign some Talking Therapies sites to an experimental group, and others to a control group.
The TherapyMatch-D computer programme will give a personalised treatment recommendation to some patients in the experimental group.
This recommendation is based on an artificial intelligence programme that was developed in prior research. In the control group, no treatment recommendation will be provided. In this way, we will be able to assess if the TherapyMatch-D treatment selection recommendations help to improve outcomes.
Why is it important?
Your participation will help us to learn if using the TherapyMatch-D artificial intelligence method helps us to make better treatment selection recommendations for patients accessing high intensity talking therapies for depression.
How can I find out more?
This study is no longer looking for new participants but is still ongoing.
If you are a clinician or if you have questions for the research team, click the button below to email the research team:
Meet the researcher
Irini VerbistResearch Fellow
My name is Irini Verbist and I am a research associate for Talking Therapies Division in GMMH. My current area of focus is the increase of access and engagement with Talking Therapies, the improvement of treatment outcomes in vulnerable groups and minorities, and the evaluation of therapy deliveries. To better understand clients' needs I work with routine data, online surveys and focus groups. I also lead Patient and Public Involvement (PPI) groups to inform strategic services priorities and increase public involvement in research activities.